[Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
Veralipride is a substituted benzamide which is used for the treatment of menopausal hot flushes. We report five cases with extrapyramidal disorders associated to a treatment with this drug for which the neuroleptic activity resulting from an interaction with D2 receptors is not always known by prescribers. One case consisted of acute dyskinesias and four of parkinsonian syndromes, one of these being associated with tardive dyskinesia. In these four cases, dosing recommendations were not respected.
Masmoudi
K
K
Service de Neurologie, CHU d'Amiens, Hôpital Nord et Sud, France.
Decocq
G
G
Chetaille
E
E
Rosa
A
A
Mizon
J P
JP
Andréjak
M
M
D000208:Acute Disease; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D005483:Flushing / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D013469:Sulpiride; C027429:veralipride
Troubles extrapyramidaux induits par le véralipride (Agréal). A propos de cinq observations.